SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-15-000342
Filing Date
2015-08-04
Accepted
2015-08-04 18:53:09
Documents
1
Period of Report
2015-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 4002
  Complete submission text file 0001192482-15-000342.txt   5508
Mailing Address ZYNERBA PHARMACEUTICALS, INC. 170 N. RADNOR-CHESTER ROAD RADNOR PA 19087
Business Address
Sebree Terri B (Reporting) CIK: 0001297912 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37526 | Film No.: 151026995

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations